Skafar, Vera
de Souza, Izadora
Ghosh, Biplab
Ferreira dos Santos, Ancely https://orcid.org/0000-0003-4985-6187
Porto Freitas, Florencio https://orcid.org/0000-0002-0369-4488
Chen, Zhiyi
Sun, Shibo https://orcid.org/0000-0002-3019-1413
Donate Castillo, Merce https://orcid.org/0009-0004-2677-5506
Nepachalovich, Palina
Seufert, Lars https://orcid.org/0009-0009-9268-4377
Bothe, Sebastian
Tschuck, Juliane https://orcid.org/0000-0002-3144-6027
Mathur, Apoorva https://orcid.org/0009-0007-0209-8362
Nunes-Alves, Ariane https://orcid.org/0000-0002-5488-4732
Buhr, Jannik https://orcid.org/0000-0002-9350-2629
Aponte-SantamarÃa, Camilo
Schmitz, Werner
Mack, Matthias https://orcid.org/0000-0002-7753-2422
Eilers, Martin https://orcid.org/0000-0002-0376-6533
Bargou, Ralf
Chaufan, Milena https://orcid.org/0009-0001-3360-6071
Kaur, Mayher
Palma, Mario https://orcid.org/0009-0007-9456-2096
Ubellacker, Jessalyn M. https://orcid.org/0000-0002-7855-9125
Elling, Ulrich https://orcid.org/0000-0002-4514-2809
Augustin, Hellmut G.
Hadian, Kamyar https://orcid.org/0000-0001-8727-2575
Meierjohann, Svenja
Proneth, Bettina https://orcid.org/0000-0002-4119-9437
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Fedorova, Maria https://orcid.org/0000-0002-4692-3885
Alborzinia, Hamed
Friedmann Angeli, José Pedro https://orcid.org/0000-0001-7706-1379
Article History
Received: 8 February 2025
Accepted: 11 December 2025
First Online: 13 March 2026
Competing interests
: M. Conrad and B.P. are co-founders and shareholders of ROSCUE Therapeutics GmbH. The remaining authors declare no competing interests.